Navigation Links
Valeant Pharmaceuticals Responds to Cephalon Board's Letter
Date:4/21/2011

nal specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.

Forward-looking Statements

Certain statements made in this press release may constitute forward-looking statements of Valeant, including, but not limited to, statements regarding our offer to purchase Cephalon, financing related to the proposed transaction, our consent solicitation process or our intention to commence a tender offer, our opportunities and our plans should we acquire Cephalon, the effect of the proposed transaction on financial results, and certain financial projections.  Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions.  These statements are based upon the current expectations and beliefs of management of Valeant and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.  These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Valeant's most recent annual or quarterly report filed with the Securities and Exchange Commission ("SEC") and Canadian Securities Administrators ("CSA") and other risks and uncertainties as discussed from time to time in Valeant's filings with the SEC and the CSA, which disclosures are incorporated herein by reference.  Readers are cautioned not to place undue reliance on any of these forward-looking statements.  Valeant undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press r
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
2. Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
3. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
4. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
5. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
6. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
7. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
8. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
9. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
10. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
11. Valeant Announces Pricing of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... Md., Dec. 21, 2011 The U.S. Food and Drug ... Flex Massager, imported by King International and sold by ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) The Shoulder Flex Massager is ... over the Internet. It is intended to provide users with ...
... NEW YORK, Dec. 21, 2011   Delcath Systems, Inc. ... to the Company,s Medical Advisory Board. ... the International Liver Cancer Association (ILCA), Dr. Gores will ... drug induced liver pathology to our Medical Advisory Board," ...
Cached Medicine Technology:FDA: Do Not Use ShoulderFlex Massagers 2FDA: Do Not Use ShoulderFlex Massagers 3Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 2Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 3Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 4
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... 2010 DePuy hip recall continue to move forward in ... According to documents filed in California’s San Francisco Superior ... seeking an expedited trial of her DePuy hip lawsuit ... v. DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Western University ... its status of “Full Accreditation” for the next seven ... on Education (COE). , “This is a magnificent achievement, ... hard work and student outcomes,” said College of Veterinary ... express my appreciation to the faculty, staff, preceptors, and ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 With Memorial Day ... Amica Insurance is offering tips to help prevent ... National Fire Protection Association (NFPA) reports that gas grills ... and 2010. Charcoal or other solid-fueled grills, meanwhile, caused approximately ... As a result, Amica Insurance is sharing the following tips ...
(Date:5/24/2013)... E-Dentists.com has announced the launch of ... Media Surge, a leading medical Internet marketing agency. ... service will focus on providing dentists the help they ... their competitive keywords. The dental SEO analysis covers a ... on what their competitors are doing right. The goal ...
(Date:5/24/2013)... Drugs commonly used to treat glaucoma may cause droopy ... vision, according to a new study. The drugs, ... reduce eye pressure, have already been shown to cause ... researchers said, suggesting that the new findings could lead ... be conservative when prescribing these drugs, the researchers added, ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2
... into the gut, according to a study published this ... There are several drugs that would have more ... absorption by the lower intestine. However, in order to ... medication delivered by mouth must surmount several barriers including ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, ... and older white Americans are sicker than their counterparts in ... long as the Brits, thanks to doctors and drugs. ... care from the health-care system," explained study co-author James P. ...
... biceps (LHB) tendinopathy, which is a pain and/or tearing ... and/or a rotator cuff tear. LHB tendinopahy can be ... Because of the variety of the causes and the ... examination, including radiographic imaging to determine the diagnosis and ...
... a safe, effective way of removing bowel tumours and ... colorectal cancer, according to researchers from the University of ... time in hospital and recover more quickly from the ... way of doing surgery does not make patients with ...
... that multiple antiepileptic drugs (AEDs) used by pregnant women ... their teenagers. The research team from Karolinska University Hospital ... exposure to AEDs in utero may have a negative ... Epilepsia , a journal published by Wiley-Blackwell on ...
... , WEDNESDAY, Nov. 3 (HealthDay News) -- Higher levels ... care for Medicare patients, a new study has found. ... and Information Set revealed wide variation across the United ... of inappropriate prescriptions for the elderly, said the researchers ...
Cached Medicine News:Health News:Colonic navigation 2Health News:Older Americans Sicker Than British Peers... 2Health News:5-year results show keyhole bowel cancer surgery is safe and effective 2Health News:Teens of epileptic moms display poor school performance 2Health News:Pricey Drugs May Not Mean Better Care 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: